NEW YORK: Bill Price has exited his role as VP of media relations at Johnson & Johnson to join Pfizer Animal Health as senior director of corporate communications.
In his new role, Price is responsible for financial media relations, as well as communications related to global manufacturing and supply chains. He started the job last month.
“I am excited to be joining the communications team in Pfizer Animal Health as the company considers plans for a potential [initial public offering] in that business' future,” Price said.
Pfizer is working toward an IPO of shares of its animal health business. The name of the new standalone company will be Zoetis. Last month, The Wall Street Journal reported that Pfizer is considering a January or February IPO of about $4 billion for the unit.
Price could not comment further on his position as the company pursues plans for an IPO.
Late last spring, Pfizer hired a PR firm in an effort to promote the animal health business as it sought buyers.
Price's departure came just three months after Ray Jordan vacated his corporate VP of public affairs and corporate communication post to join Amgen. J&J has yet to select a replacement for Jordan, a company representative said.
J&J's communications group has seen several personnel changes in the last two years, including the departure of Marc Monseau, director of corporate communications and social media, in 2011. Bonnie Jacobs left her role as VP of communications last spring.
At the beginning of last year, J&J appointed Michael Sneed to oversee its global PR and marketing functions as VP of global corporate affairs. He has managed Jordan's direct reports since his September departure.
J&J declined to comment on Price's departure. A representative from Pfizer confirmed the hire, but declined to comment further.